Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children
Open accessThe DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
Early-life antibiotic use is associated with increased risk for metabolic and immunological diseases, and mouse studies indicate a causal role of the disrupted microbiome. However, little is known about the impacts of antibiotics on the developing microbiome of children. Here we use phylogenetics, metagenomics and individual antibiotic purchase records to show that macrolide use in 2-7 year-old Finnish children (N=142; sampled at two time points) is associated with a long-lasting shift in microbiota composition and metabolism. The shift includes depletion of Actinobacteria, increase in Bacteroidetes and Proteobacteria, decrease in bile-salt hydrolase and increase in macrolide resistance. Furthermore, macrolide use in early life is associated with increased risk of asthma and predisposes to antibiotic-associated weight gain. Overweight and asthmatic children have distinct microbiota compositions. Penicillins leave a weaker mark on the microbiota than macrolides. Our results support the idea that, without compromising clinical practice, the impact on the intestinal microbiota should be considered when prescribing antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“an induction of ARGs, and a decrease in bile salt hydrolases”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [89]
In the citing paper
“Such profile positively correlated with either a later development of asthma, or an increase in body mass index [89].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [89]
In the citing paper
“Early use of macrolides in Finnish children was found to generate a distinct microbial profile characterized by a loss of Actinobacteriaceae and an increase in Bacteroidetes and Proteobacteria”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Modern Applied Statistics with S
Venables, W. N., & Ripley, B. D. (2002) · Statistics and Computing · doi:10.1007/978-0-387-21706-2 · Cited by 24,305
UCHIME improves sensitivity and speed of chimera detection
Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C., & Knight, R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr381 · Cited by 15,114
The control of the false discovery rate in multiple testing under dependency
Benjamini, Y., & Yekutieli, D. (2001) · The Annals of Statistics · doi:10.1214/aos/1013699998 · Cited by 10,490
Klindworth, A., Pruesse, E., Schweer, T., Peplies, J., Quast, C., Horn, M., & Glöckner, F. O. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks808 · Cited by 8,850
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
Richness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662
Human Genetics Shape the Gut Microbiome
Goodrich, J. K., Waters, J. L., Poole, A. C., Sutter, J. L., Koren, O., Blekhman, R., Beaumont, M., Van Treuren, W., Knight, R., Bell, J. T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.053 · Cited by 3,164
Waste Not, Want Not: Why Rarefying Microbiome Data Is Inadmissible
McMurdie, P. J., & Holmes, S. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003531 · Cited by 2,921
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
Cited by
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
Milani, C., Duranti, S., Bottacini, F., Casey, E., Turroni, F., Mahony, J., Belzer, C., Delgado Palacio, S., Arboleya Montes, S., Mancabelli, L., et al. (2017) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00036-17 · Cited by 1,950
“When the infant microbiota is exposed to antibiotics the diversity can drop to an even lower value compared to that of a reference non-antibiotic-treated, breastfed infant (2, 457).”
BackgroundPopulation-based metagenomics analysis reveals markers for gut microbiome composition and diversity
Zhernakova, A., Kurilshikov, A., Bonder, M. J., Tigchelaar, E. F., Schirmer, M., Vatanen, T., Mujagic, Z., Vila, A. V., Falony, G., Vieira-Silva, S., et al. (2016) · Science · doi:10.1126/science.aad3369 · Cited by 1,914
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
Malfertheiner, P., Megraud, F., Rokkas, T., Gisbert, J. P., Liou, J.-M., Schulz, C., Gasbarrini, A., Hunt, R. H., Leja, M., O'Morain, C., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327745 · Cited by 1,533
Antibiotics, birth mode, and diet shape microbiome maturation during early life
Bokulich, N. A., Chung, J., Battaglia, T., Henderson, N., Jay, M., Li, H., D. Lieber, A., Wu, F., Perez-Perez, G. I., Chen, Y., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad7121 · Cited by 1,469
Microbes, Metabolites, and the Gut-Lung Axis
Dang, A. T., & Marsland, B. J. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0160-6 · Cited by 1,028
The gut microbiome: Relationships with disease and opportunities for therapy
Durack, J., & Lynch, S. V. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20180448 · Cited by 943
“, 2017), antimicrobial administration (Johnson et al., 2005; Korpela et al., 2016; Ahmadizar et al., 2017; Yamamoto-Hanada et al., 2017), formula feeding, exposure to furred pets, and environmental toxins (Levin et al.”
BackgroundAntibiotics as Major Disruptors of Gut Microbiota
Ramirez, J., Guarner, F., Bustos Fernandez, L., Maruy, A., Sdepanian, V. L., & Cohen, H. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.572912 · Cited by 898
“Numerous studies have shown links between changes in the composition of the gut microbiota and diseases, including recurrent diarrhea associated with C. difficile, some bowel disorders (including IBD), colorectal cancer, non-alcoholic steatohepatitis, type 2 diabetes, obesity, and advanced chronic liver disease (Duval…”
BackgroundInfluentialAntibiotic-Induced Changes in the Intestinal Microbiota and Disease
Becattini, S., Taur, Y., & Pamer, E. G. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.04.003 · Cited by 901
“This profile positively correlated with either a later development of asthma or an increase in body mass index [89].”
BackgroundThe human gut microbiome in early-onset type 1 diabetes from the TEDDY study
Vatanen, T., Franzosa, E. A., Schwager, R., Tripathi, S., Arthur, T. D., Vehik, K., Lernmark, Å., Hagopian, W. A., Rewers, M. J., She, J.-X., et al. (2018) · Nature · doi:10.1038/s41586-018-0620-2 · Cited by 886
Recovery of gut microbiota of healthy adults following antibiotic exposure
Palleja, A., Mikkelsen, K. H., Forslund, S. K., Kashani, A., Allin, K. H., Nielsen, T., Hansen, T. H., Liang, S., Feng, Q., Zhang, C., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0257-9 · Cited by 875
Self-citationAntibiotic use and its consequences for the normal microbiome
Blaser, M. J. (2016) · Science · doi:10.1126/science.aad9358 · Cited by 836
“We must clearly understand the real costs, including the differences between particular antimicrobial agents in their effects on the microbiome (11) and, thus, the consequent sequelae on child development (12).”
BackgroundImpact of antibiotics on the human microbiome and consequences for host health
Patangia, D. V., Anthony Ryan, C., Dempsey, E., Paul Ross, R., & Stanton, C. (2022) · MicrobiologyOpen · doi:10.1002/mbo3.1260 · Cited by 754
“Antibiotic use during infancy and childhood has been associated with the altered microbial composition and metabolic functions (Korpela et al.,2016), higher risk of asthma and allergy development (Ni et al., 2019; Yamamoto‐ Hanada et al., 2017), and obesity (L. C. Bailey et al., 2014) in later life.”
BackgroundMechanisms and consequences of intestinal dysbiosis
Weiss, G. A., & Hennet, T. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2509-x · Cited by 775
“Whereas several antibiotics, such as amoxicillin, do not have any significant long-term impact on the gut microbiota , treatment of children with macrolide antibiotics lead to long-lasting decrease in Firmicutes and Actinobacteria with concomitant increase in Bacteroidetes and Proteobacteria [90].”
BackgroundInfluentialThe Gut Microbiota in the First Decade of Life
Derrien, M., Alvarez, A.-S., & de Vos, W. M. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2019.08.001 · Cited by 635
“In particular, the gut microbiota has been followed in children exposed to two classes of antibiotic (macrolides and penicillins) [88].”
BackgroundAntibiotics as deep modulators of gut microbiota: between good and evil
Ianiro, G., Tilg, H., & Gasbarrini, A. (2016) · Gut · doi:10.1136/gutjnl-2016-312297 · Cited by 625
“21 In the same cohort, interestingly, penicillins — in particular, penicillin V and amoxicillin — were not associated with relevant changes of microbiota.”
BackgroundEffects of Psychological, Environmental and Physical Stressors on the Gut Microbiota
Karl, J. P., Hatch, A. M., Arcidiacono, S. M., Pearce, S. C., Pantoja-Feliciano, I. G., Doherty, L. A., & Soares, J. W. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02013 · Cited by 530
Lazar, V., Ditu, L.-M., Pircalabioru, G. G., Gheorghe, I., Curutiu, C., Holban, A. M., Picu, A., Petcu, L., & Chifiriuc, M. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01830 · Cited by 525
“and Proteobacteria levels (196) and decrease the abundance of Actinobacteria and Firmicutes taxa.”
BackgroundWiertsema, S. P., van Bergenhenegouwen, J., Garssen, J., & Knippels, L. M. J. (2021) · Nutrients · doi:10.3390/nu13030886 · Cited by 512
Interactions between gut bacteria and bile in health and disease
Long, S. L., Gahan, C. G. M., & Joyce, S. A. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.06.002 · Cited by 495
Autism Spectrum Disorders and the Gut Microbiota
Fattorusso, A., Di Genova, L., Dell’Isola, G., Mencaroni, E., & Esposito, S. (2019) · Nutrients · doi:10.3390/nu11030521 · Cited by 484
“Antibiotic treatments, even if undertaken for a brief period, may induce long-lasting alterations in the gut microbiota, both in humans and in animal models [48,49].”
BackgroundAkkermansia muciniphila in the Human Gastrointestinal Tract: When, Where, and How?
Geerlings, S. Y., Kostopoulos, I., De Vos, W. M., & Belzer, C. (2018) · Microorganisms · doi:10.3390/microorganisms6030075 · Cited by 446
“muciniphila-based sequences were found to be reduced in children that had received multiple antibiotic courses and were at risk for later life obesity [17].”
BackgroundRole of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction
Bouter, K. E., van Raalte, D. H., Groen, A. K., & Nieuwdorp, M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.12.048 · Cited by 431
Diet, Microbiota and Gut-Lung Connection
Anand, S., & Mande, S. S. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02147 · Cited by 409
“example, microbial dysbiosis due to the use of macrolides in early life (which depletes Actinobacteria and increases abundances of Bacteroidetes and Proteobacteria) is correlated with an increased risk of asthma in 2–7 years old Finnish children (Korpela et al., 2016).”
BackgroundFlandroy, L., Poutahidis, T., Berg, G., Clarke, G., Dao, M.-C., Decaestecker, E., Furman, E., Haahtela, T., Massart, S., Plovier, H., et al. (2018) · Science of The Total Environment · doi:10.1016/j.scitotenv.2018.01.288 · Cited by 394
“, 2016), and above all a major influence of antibiotics (Jernberg et al., 2010; Korpela et al., 2016).”
Unravelling the collateral damage of antibiotics on gut bacteria
Maier, L., Goemans, C. V., Wirbel, J., Kuhn, M., Eberl, C., Pruteanu, M., Müller, P., Garcia-Santamarina, S., Cacace, E., Zhang, B., et al. (2021) · Nature · doi:10.1038/s41586-021-03986-2 · Cited by 391
The human microbiome in evolution
Davenport, E. R., Sanders, J. G., Song, S. J., Amato, K. R., Clark, A. G., & Knight, R. (2017) · BMC Biology · doi:10.1186/s12915-017-0454-7 · Cited by 393
Interaction of the microbiota with the human body in health and diseases
ALTVEŞ, S., YILDIZ, H. K., & VURAL, H. C. (2020) · Bioscience of Microbiota, Food and Health · doi:10.12938/bmfh.19-023 · Cited by 389
“This dysbiosis positively correlated with development of asthma or increased body mass in these children [43].”
BackgroundThirty Years of Lactobacillus rhamnosus GG: A Review
Capurso, L. (2019) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001170 · Cited by 381
RETRACTED ARTICLE: Role of the gut microbiome in chronic diseases: a narrative review
Vijay, A., & Valdes, A. M. (2022) · European Journal of Clinical Nutrition · doi:10.1038/s41430-021-00991-6 · Cited by 361
RetractedKorpela, K., Helve, O., Kolho, K.-L., Saisto, T., Skogberg, K., Dikareva, E., Stefanovic, V., Salonen, A., Andersson, S., & de Vos, W. M. (2020) · Cell · doi:10.1016/j.cell.2020.08.047 · Cited by 359
Okeke, E. S., Chukwudozie, K. I., Nyaruaba, R., Ita, R. E., Oladipo, A., Ejeromedoghene, O., Atakpa, E. O., Agu, C. V., & Okoye, C. O. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-22319-y · Cited by 316
“Macrolides Erythromycin, azithromycin, and clarithromycin Shift in the intestinal flora composition Affects the metabolism of human gut (Korpela et al. 2016)”
BackgroundGut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy
Shen, Y., Fan, N., Ma, S., Cheng, X., Yang, X., & Wang, G. (2025) · MedComm · doi:10.1002/mco2.70168 · Cited by 301
“Long time use may result in lasting alterations in the microbiota composition [22].”
Antibiotic use and microbiome function
Ferrer, M., Méndez-García, C., Rojo, D., Barbas, C., & Moya, A. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.09.007 · Cited by 299
Sherwin, E., Sandhu, K. V., Dinan, T. G., & Cryan, J. F. (2016) · CNS Drugs · doi:10.1007/s40263-016-0370-3 · Cited by 295
“Recently, Korpela and colleagues [73] showed that a course of macrolide antibiotics was capable of inducing long-lasting alterations in the composition of the microbiota in children, which was associated with development of obesity and asthma.”
BackgroundBrown, R. G., Marchesi, J. R., Lee, Y. S., Smith, A., Lehne, B., Kindinger, L. M., Terzidou, V., Holmes, E., Nicholson, J. K., Bennett, P. R., et al. (2018) · BMC Medicine · doi:10.1186/s12916-017-0999-x · Cited by 295
“[45], rising resistance [46] and recent association with increased risk of cerebral palsy, epilepsy [42, 47] as well as asthma and obesity [48].”
BackgroundThe prenatal gut microbiome: are we colonized with bacteria in utero ?
Walker, R. W., Clemente, J. C., Peter, I., & Loos, R. J. F. (2017) · Pediatric Obesity · doi:10.1111/ijpo.12217 · Cited by 293
Microbiome effects on immunity, health and disease in the lung
Shukla, S. D., Budden, K. F., Neal, R., & Hansbro, P. M. (2017) · Clinical & Translational Immunology · doi:10.1038/cti.2017.6 · Cited by 287
Tseng, C.-H., & Wu, C.-Y. (2019) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.07.009 · Cited by 280
Evaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans
Meijnikman, A. S., Gerdes, V. E., Nieuwdorp, M., & Herrema, H. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00192 · Cited by 278
Perinatal factors affect the gut microbiota up to four years after birth
Fouhy, F., Watkins, C., Hill, C. J., O’Shea, C.-A., Nagle, B., Dempsey, E. M., O’Toole, P. W., Ross, R. P., Ryan, C. A., & Stanton, C. (2019) · Nature Communications · doi:10.1038/s41467-019-09252-4 · Cited by 274
Bloomfield, S. F., Rook, G. A., Scott, E. A., Shanahan, F., Stanwell-Smith, R., & Turner, P. (2016) · Perspectives in Public Health · doi:10.1177/1757913916650225 · Cited by 270
“92, 93 Antibiotics, particularly macrolides, have lasting effects on the microbiota of young children and increase risks of asthma.”
BackgroundAntimicrobial Activity and Resistance: Influencing Factors
Li, J., Xie, S., Ahmed, S., Wang, F., Gu, Y., Zhang, C., Chai, X., Wu, Y., Cai, J., & Cheng, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00364 · Cited by 266
“The usage of antibiotic is found to lead into a reduction in species richness and treatment with specific antibiotics resulted in an enrichment of specific sets of antibiotic resistance genes that are associated with a single species (Gibson et al., 2016; Korpela et al., 2016).”
BackgroundAntibiotics in early life: dysbiosis and the damage done
Neuman, H., Forsythe, P., Uzan, A., Avni, O., & Koren, O. (2018) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuy018 · Cited by 259
Shetty, S. A., Hugenholtz, F., Lahti, L., Smidt, H., & de Vos, W. M. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuw045 · Cited by 255
“Furthermore, stochastic factors such as colonization order or antibiotic exposure can also affect microbial colonization (Lederberg and McCray 2001; Harris et al. 2015; Korpela et al. 2016).”
BackgroundThe Relationship Between Gut Microbiota and Inflammatory Diseases: The Role of Macrophages
Wang, J., Chen, W.-D., & Wang, Y.-D. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01065 · Cited by 253
Pseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics
Wood, S. J., Kuzel, T. M., & Shafikhani, S. H. (2023) · Cells · doi:10.3390/cells12010199 · Cited by 254
McDonnell, L., Gilkes, A., Ashworth, M., Rowland, V., Harries, T. H., Armstrong, D., & White, P. (2021) · Gut Microbes · doi:10.1080/19490976.2020.1870402 · Cited by 248
“Nearly all studies reported the short-term associations between antibiotic exposure (up to 1 month) and microbiome composition; some also reported longer-term outcomes up to 2 years and 4 years.(33,37,29,42) Microbiome richness Microbiome richness (Table 6) data were available for 3 studies and are shown in Table 2.”
BackgroundResultInfluentialPancu, D. F., Scurtu, A., Macasoi, I. G., Marti, D., Mioc, M., Soica, C., Coricovac, D., Horhat, D., Poenaru, M., & Dehelean, C. (2021) · Antibiotics · doi:10.3390/antibiotics10040401 · Cited by 244
Contributions of the intestinal microbiome in lung immunity
McAleer, J. P., & Kolls, J. K. (2018) · European Journal of Immunology · doi:10.1002/eji.201646721 · Cited by 243
“Specifically, macrolide use between ages 2-7 resulted in a long-lasting shift in microbiota (decreased Actinobacteria, increased Bacteroidetes and Proteobacteria), metabolism (decreased bile salt hydrolase), and increased prevalence of asthma (86).”
BackgroundMunukka, E., Ahtiainen, J. P., Puigbó, P., Jalkanen, S., Pahkala, K., Keskitalo, A., Kujala, U. M., Pietilä, S., Hollmén, M., Elo, L., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02323 · Cited by 237
“Hence, also the responsiviness of an individual to certain lifestyle changes, such as dietary intervention or increased physical activity varies greatly (Korpela and de Vos, 2016; Korpela et al., 2016) creating a challenge in studies designed to modify the gut microbiota.”
BackgroundBharwani, A., Mian, M. F., Surette, M. G., Bienenstock, J., & Forsythe, P. (2017) · BMC Medicine · doi:10.1186/s12916-016-0771-7 · Cited by 236
“Certain factors impart transient changes in the community, while others, for instance, antibiotic usage, leave behind a more persistent signature [67, 68].”
BackgroundNogacka, A., Salazar, N., Suárez, M., Milani, C., Arboleya, S., Solís, G., Fernández, N., Alaez, L., Hernández-Barranco, A. M., de los Reyes-Gavilán, C. G., et al. (2017) · Microbiome · doi:10.1186/s40168-017-0313-3 · Cited by 236
“Actually, repeated exposure to β-lactam antibiotics during infancy has been related with an increased weight in later life [61], and the intestinal microbiome of infants has been repeatedly reported to be affected by antibiotic use [21, 62].”
Metatranscriptome of human faecal microbial communities in a cohort of adult men
Abu-Ali, G. S., Mehta, R. S., Lloyd-Price, J., Mallick, H., Branck, T., Ivey, K. L., Drew, D. A., DuLong, C., Rimm, E., Izard, J., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-017-0084-4 · Cited by 233
Transmission of the gut microbiota: spreading of health
Browne, H. P., Neville, B. A., Forster, S. C., & Lawley, T. D. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.50 · Cited by 232
Elvers, K. T., Wilson, V. J., Hammond, A., Duncan, L., Huntley, A. L., Hay, A. D., & van der Werf, E. T. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035677 · Cited by 225
Anthony, W. E., Wang, B., Sukhum, K. V., D’Souza, A. W., Hink, T., Cass, C., Seiler, S., Reske, K. A., Coon, C., Dubberke, E. R., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110649 · Cited by 220
“Previous analyses using 16S rRNA gene amplicon data reported a reduction in species richness 1 year after children were treated with the macrolides clarithromycin and erythromycin, as well as a reduction in the abundance of Bifidobacterium and Collinsella genera (Korpela et al., 2016).”
Liou, J.-M., Chen, C.-C., Chang, C.-M., Fang, Y.-J., Bair, M.-J., Chen, P.-Y., Chang, C.-Y., Hsu, Y.-C., Chen, M.-J., Chen, C.-C., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30272-5 · Cited by 217
The composition of the perinatal intestinal microbiota in cattle
Alipour, M. J., Jalanka, J., Pessa-Morikawa, T., Kokkonen, T., Satokari, R., Hynönen, U., Iivanainen, A., & Niku, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-28733-y · Cited by 216
Microbiota effects on cancer: From risks to therapies
Rea, D., Coppola, G., Palma, G., Barbieri, A., Luciano, A., Del Prete, P., Rossetti, S., Berretta, M., Facchini, G., Perdonà, S., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24681 · Cited by 208
Early life colonization of the human gut: microbes matter everywhere
Korpela, K., & de Vos, W. M. (2018) · Current Opinion in Microbiology · doi:10.1016/j.mib.2018.06.003 · Cited by 207
Antibiotic-induced gut dysbiosis and barrier disruption and the potential protective strategies
Duan, H., Yu, L., Tian, F., Zhai, Q., Fan, L., & Chen, W. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1843396 · Cited by 207
Respiratory microbiome and epithelial interactions shape immunity in the lungs
Invernizzi, R., Lloyd, C. M., & Molyneaux, P. L. (2020) · Immunology · doi:10.1111/imm.13195 · Cited by 193
“148 It is clear that we need to appreciate the interactions between the gut and airway microbiota in order to understand the impact of antibiotics on lung health.”
BackgroundDuong, Q. A., Pittet, L. F., Curtis, N., & Zimmermann, P. (2022) · Journal of Infection · doi:10.1016/j.jinf.2022.01.005 · Cited by 192
Causality of small and large intestinal microbiota in weight regulation and insulin resistance
Scheithauer, T. P. M., Dallinga-Thie, G. M., de Vos, W. M., Nieuwdorp, M., & van Raalte, D. H. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.06.002 · Cited by 188
“For example, antibiotic use at a young age is associated with higher weight gain [69].”
BackgroundBrodmann, T., Endo, A., Gueimonde, M., Vinderola, G., Kneifel, W., de Vos, W. M., Salminen, S., & Gómez-Gallego, C. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01725 · Cited by 191
“Similarly, pre-school infants that used macrolide antibiotics showed a higher BMI than the non-antibiotic users and this was associated with a depletion of A.muciniphila (Korpela et al., 2016).”
BackgroundLuo, G., Li, B., Li, L.-G., Zhang, T., & Angelidaki, I. (2017) · Environmental Science & Technology · doi:10.1021/acs.est.6b05100 · Cited by 189
“PCRRF16009) and The 487 Danish Council for Independent Research (12-126632) and Strategic Research 488 (12-132654).”
BackgroundGut Microbiome and Antibiotics
Iizumi, T., Battaglia, T., Ruiz, V., & Perez Perez, G. I. (2017) · Archives of Medical Research · doi:10.1016/j.arcmed.2017.11.004 · Cited by 187
Another renaissance for bile acid gastrointestinal microbiology
Ridlon, J. M., & Gaskins, H. R. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00896-2 · Cited by 183
“Indeed, a longitudinal study in children (age 2–7 years; n = 142) supports an inverse association between BSH and weight gain caused by macrolide antibiotic treatment 90 .”
von Martels, J. Z. H., Sadaghian Sadabad, M., Bourgonje, A. R., Blokzijl, T., Dijkstra, G., Faber, K. N., & Harmsen, H. J. M. (2017) · Anaerobe · doi:10.1016/j.anaerobe.2017.01.001 · Cited by 184
Do bacteria shape our development? Crosstalk between intestinal microbiota and HPA axis
de Weerth, C. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.09.016 · Cited by 181
“Antibiotics have been shown to disrupt the colonization process, producing long-lasting alterations in the composition and metabolic activity of the gut microbiota (Korpela et al., 2016).”
Microbiota–Gut–Brain Axis and Epilepsy: A Review on Mechanisms and Potential Therapeutics
Ding, M., Lang, Y., Shu, H., Shao, J., & Cui, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.742449 · Cited by 169
Pursuing Human-Relevant Gut Microbiota-Immune Interactions
Spencer, S. P., Fragiadakis, G. K., & Sonnenburg, J. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.08.002 · Cited by 161
“The dynamic nature of the microbiota also leaves it vulnerable to perturbing forces, such as antibiotics or industrialized diets, which result in persistent or compounding deterioration of the gut community over generations in mouse models(Dethlefsen and Relman, 2011; Korpela et al., 2016; Schulfer et al., 2018; Sonne…”
BackgroundThe infant gut bacterial microbiota and risk of pediatric asthma and allergic diseases
Johnson, C. C., & Ownby, D. R. (2017) · Translational Research · doi:10.1016/j.trsl.2016.06.010 · Cited by 160
“2 years after macrolide use) changes in gut microbes and with increased risk of asthma and weight gain.(41) Thus, epidemiologic evidence suggests that early events in gut microbial exposure and colonization may play key roles in development of disease at sites remote from the GI tract and that gut microbiota influence…”
Lappan, R., Imbrogno, K., Sikazwe, C., Anderson, D., Mok, D., Coates, H., Vijayasekaran, S., Bumbak, P., Blyth, C. C., Jamieson, S. E., et al. (2018) · BMC Microbiology · doi:10.1186/s12866-018-1154-3 · Cited by 162
“In the gut microbiome of children, reduced richness can persist for up to 2 years after the use of macrolides [96].”
BackgroundLiu, Q., Tian, X., Maruyama, D., Arjomandi, M., & Prakash, A. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00421.2020 · Cited by 161
Shu, S.-A., Yuen, A. W. T., Woo, E., Chu, K. H., Kwan, H. S., Yang, G., Yang, Y., & Leung, P. S. C. (2018) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-018-8723-y · Cited by 176
Bertollo, A. G., Santos, C. F., Bagatini, M. D., & Ignácio, Z. M. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1541075 · Cited by 211
Govindarajan, K., MacSharry, J. A., Casey, P. G., Shanahan, F., Joyce, S. A., & Gahan, C. G. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167319 · Cited by 164
“For instance diet [27], antibiotics [28] or other medications [29] or probiotics [30] have been shown to alter microbial metabolism of bile acids through altered BSH activity and these perturbations may therefore have the potential to alter chronobiological signalling events through bile acid signalling.”
BackgroundNamasivayam, S., Maïga, M., Yuan, W., Thovarai, V., Costa, D. L., Mittereder, L. R., Wipperman, M. F., Glickman, M. S., Dzutsev, A., Trinchieri, G., et al. (2017) · Microbiome · doi:10.1186/s40168-017-0286-2 · Cited by 170
Diet, Microbiota, and Metabolic Health: Trade-Off Between Saccharolytic and Proteolytic Fermentation
Korpela, K. (2018) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-030117-012830 · Cited by 173
Tiny microbes, enormous impacts: what matters in gut microbiome studies?
Debelius, J. W., Song, S. J., Vázquez‐Baeza, Y., Xu, Z. Z., González, A., & Knight, R. D. (2016) · Genome biology · doi:10.1186/s13059-016-1086-x · Cited by 178
“Antibiotic use [55, 56, 58, 59] Antibiotics have a structure and lowe and different antib”
BackgroundInfluentialNext-generation sequencing: big data meets high performance computing
Schmidt, B., & Hildebrandt, A. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.01.014 · Cited by 154
Feng, P., Ye, Z., Kakade, A., Virk, A. K., Li, X., & Liu, P. (2018) · Nutrients · doi:10.3390/nu11010022 · Cited by 166
The varying effects of antibiotics on gut microbiota
Yang, L., Bajinka, O., Jarju, P. O., Tan, Y., Taal, A. M., & Özdemir, G. (2021) · AMB Express · doi:10.1186/s13568-021-01274-w · Cited by 169
Human Gut Microbiota: Toward an Ecology of Disease
Selber‐Hnatiw, S., Rukundo, B., Ahmadi, M., Akoubi, H., Al-Bizri, H., Aliu, A. F., Ambeaghen, T. U., Avetisyan, L., Bahar, I., Baird, A., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01265 · Cited by 162
“…countries because of lifestyle modifications that impoverish the microbiota, including excessive hygiene, liberal use of antibiotics and a high-fat diet (Strachan, 1989; WillsKarp et al., 2001; Vercelli, 2009, 2010; Von Mutius and Vercelli, 2010; Allan and Devereux, 2011; Korpela et al., 2016).”
BackgroundArshad, M. A., Hassan, F., Rehman, M. S.-U., Huws, S., Cheng, Y., & Din, A. U. (2021) · Animal nutrition · doi:10.1016/j.aninu.2021.03.004 · Cited by 165
Factors influencing the gut microbiome in children: from infancy to childhood
Kumbhare, S. V., Patangia, D. V., Patil, R. H., Shouche, Y. S., & Patil, N. P. (2019) · Journal of Biosciences · doi:10.1007/s12038-019-9860-z · Cited by 143
“Also, it was noted that penicillin use did not have as severe an influence on the microbiota, suggesting the varying influence of distinct antibiotics (Korpela et al. 2016).”
BackgroundBile Salt Hydrolases: At the Crossroads of Microbiota and Human Health
Bourgin, M., Kriaa, A., Mkaouar, H., Mariaule, V., Jablaoui, A., Maguin, E., & Rhimi, M. (2021) · Microorganisms · doi:10.3390/microorganisms9061122 · Cited by 161
“Additionally, the gut microbiota analysis of antibiotic-treated children revealed a correlation between body weight gain and prolonged reduction in overall BSH gene abundance [69].”
BackgroundAntibiotic-induced collateral damage to the microbiota and associated infections
de Nies, L., Kobras, C. M., & Stracy, M. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00936-9 · Cited by 169
Childhood BMI in relation to microbiota in infancy and lifetime antibiotic use
Korpela, K., Zijlmans, M. A. C., Kuitunen, M., Kukkonen, A. K., Savilahti, E., Salonen, A., de Weerth, C., & de Vos, W. M. (2017) · Microbiome · doi:10.1186/s40168-017-0245-y · Cited by 152
Ruiz, V. E., Battaglia, T., Kurtz, Z. D., Bijnens, L., Ou, A., Engstrand, I., Zheng, X., Iizumi, T., Mullins, B. J., Müller, C. L., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00531-6 · Cited by 142
Ahmadizar, F., Vijverberg, S. J. H., Arets, H. G. M., de Boer, A., Lang, J. E., Garssen, J., Kraneveld, A. D., & der Zee, A. H. M. (2017) · Allergy · doi:10.1111/all.13332 · Cited by 140
“Early-life exposure to antibiotics has been related to some later life morbidities such as obesity, arthritis, asthma, and allergies.(6,7) A meta-analysis from 2006 showed a higher risk of asthma among those children exposed to antibiotics in early childhood.”
BackgroundHuang, X.-Z., Gao, P., Song, Y.-X., Xu, Y., Sun, J.-X., Chen, X.-W., Zhao, J.-H., & Wang, Z.-N. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1665973 · Cited by 132
“Moreover, it has been is well-documented that antibiotics (ATBs) can alter the diversity and composition of the commensal gut microbiota.(11) Thus, researchers hypothesize that dysbiosis of the gut microbiota caused by ATBs may be associated with resistance to ICI immunotherapy and have a negative impact on the effica…”
BackgroundInfluence of antibiotic use in early childhood on asthma and allergic diseases at age 5
Yamamoto-Hanada, K., Yang, L., Narita, M., Saito, H., & Ohya, Y. (2017) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2017.05.013 · Cited by 129
Gut Microbiota and Mucosal Immunity in the Neonate
Dzidic, M., Boix-Amorós, A., Selma‐Royo, M., Mira, Á., & Collado, M. C. (2018) · Medical Sciences · doi:10.3390/medsci6030056 · Cited by 156
Human microbiomes and antibiotic resistance
Baron, S. A., Diene, S. M., & Rolain, J. (2018) · Human Microbiome Journal · doi:10.1016/j.humic.2018.08.005 · Cited by 142
Current understanding of antibiotic-associated dysbiosis and approaches for its management
Kesavelu, D., & Jog, P. P. (2023) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361231154443 · Cited by 197
Haak, B. W., Lankelma, J. M., Hugenholtz, F., Belzer, C., de Vos, W. M., & Wiersinga, W. J. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky471 · Cited by 135
Klimenko, N. S., Tyakht, A. V., Popenko, A. S., Vasiliev, A. S., Altukhov, I. A., Ischenko, D. S., Shashkova, T. I., Efimova, D. A., Nikogosov, D. A., Osipenko, D. A., et al. (2018) · Nutrients · doi:10.3390/nu10050576 · Cited by 123
Metadata
- Authors
- Korpela, K., Salonen, A., Virta, L. J., Kekkonen, R. A., Forslund, K., Bork, P., & de Vos, W. M.
- Affiliations
- University of Helsinki (FI)
- Social Insurance Institution (FI)
- Valio (Finland) (FI)
- Venue
- Nature Communications
- Published
- 2016-01-26
- Volume
- 7
- Issue
- 1
- Pages
- 10410-10410
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4737757
- OpenAlex
- W2265709988
- Cited by
- 698
- References
- 64
- Citations by year
- 2026: 38 · 2025: 52 · 2024: 54 · 2023: 62 · 2022: 73 · 2021: 71 · 2020: 93 · 2019: 71 · 2018: 77 · 2017: 72 · 2016: 34
- FWCI
- 43.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Työväentutkimus Vuosikirja (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, cc-by)
- Funders
- Alexander von Humboldt-Stiftung
- Academy of Finland (137389, 141140, 1272870)
- FP7 Ideas: European Research Council (250172)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- gut microbiota, early-life antibiotic exposure, macrolides, penicillin, preschool children, asthma risk, bile salt hydrolase, macrolide resistance, actinobacteria, Bacteroidetes, Proteobacteria, microbiota composition, antibiotic prescribing
- MeSH terms
- Gastrointestinal Microbiome, Anti-Bacterial Agents, Bacteria, Bacterial Infections, Child, Child, Preschool, Day Care, Medical, Feces, Female, Finland, Humans, Male, Cohort Studies, Macrolides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.